FREE Account Opening + No Clearing Fees + Rs 999 API Access

Supriya Lifescience Limited IPO (Supriya Lifescience IPO) Detail

Dec 16, 2021 - Dec 20, 2021

Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic. The company has been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India between Fiscal 2017 and 2021. The company is also one of the largest exporters of Salbutamol Sulphate from India in FY 2021 in terms of volume.

In Fiscal 2021, the company's products were exported to 86 countries to 1,296 customers including 346 distributors. The company has API business in Europe, Latin America, Asia, and North America.

Supriya Lifescience has a modern manufacturing facility in Maharashtra spread across 23,806 sq. mts, having a reactor capacity of 547 KL/ day including 7 clean rooms. The company has also acquired a plot of land, admeasuring 12,551 sq. mt, near the present manufacturing facility, to expand its manufacturing infrastructure. The company's manufacturing facility has received approvals from USFDA, EDQM TGA-Australia, KFDA-Korea, PMDA Japan, NMPA (previously known as SFDA)- China, Health Canada, in relation to API products being exported to the relevant jurisdictions by the company.

Company Promoters:

Satish Waman Wagh is the company promoter.

Company Financials:

Summary of financial Information (Restated Standalone)
Particulars For the year/period ended (₹ in Millions)
  30-Sep-21 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 5,041.02 4,458.24 3,364.01 2,530.52
Total Revenue 2,300.61 3,962.21 3,227.13 2,858.62
Profit After Tax 659.59 1,238.28 733.74 394.24

Objects of the Issue:

  • Funding capital expenditure requirements of the company
  • Repayment and/ or pre-payment, in full or part, of certain borrowings availed by the company and
  • General corporate purposes

Supriya Lifescience IPO Details

IPO Opening Date Dec 16, 2021
IPO Closing Date Dec 20, 2021
Issue Type Book Built Issue IPO
Face Value ₹2 per equity share
IPO Price ₹265 to ₹274 per equity share
Market Lot 54 Shares
Min Order Quantity 54 Shares
Listing At BSE, NSE
Issue Size[.] Eq Shares of ₹2
(aggregating up to ₹700.00 Cr)
Fresh Issue[.] Eq Shares of ₹2
(aggregating up to ₹200.00 Cr)
Offer for Sale[.] Eq Shares of ₹2
(aggregating up to ₹500.00 Cr)
QIB Shares OfferedNot less than 75% of the Offer
Retail Shares OfferedNot more than 10% of the Offer
NII (HNI) Shares OfferedNot more than 15% of the Offer

Supriya Lifescience IPO Tentative Timetable

The Supriya Lifescience IPO open date is Dec 16, 2021, and the close date is Dec 20, 2021. The issue may list on Dec 28, 2021.

IPO Open Date Dec 16, 2021
IPO Close Date Dec 20, 2021
Basis of Allotment Date Dec 23, 2021
Initiation of Refunds Dec 24, 2021
Credit of Shares to Demat Account Dec 27, 2021
IPO Listing Date Dec 28, 2021

Supriya Lifescience IPO Lot Size

The Supriya Lifescience IPO market lot size is 54 shares. A retail-individual investor can apply for up to 13 lots (702 shares or ₹192,348).

Application Lots Shares Amount (Cut-off)
Minimum 1 54 ₹14,796
Maximum 13 702 ₹192,348

Supriya Lifescience IPO Promoter Holding

Pre Issue Share Holding 99.98%
Post Issue Share Holding 68.24%

Supriya Lifescience IPO Review

SLL has been making strides with higher top and bottom lines year after year and exporting over 75% of products to more than 86 countries. Based on financial parameters, the issue is attractively priced leaving something on the table across the board. The issue is worth considering for short to long term rewards. Read detail review...

Supriya Lifescience IPO Subscription Status (Bidding Detail)

The Supriya Lifescience IPO is subscribed 71.51 times on Dec 20, 2021 7:52:00 PM. The public issue subscribed 56.01 times in the retail category, 31.83 times in the QIB category, and 161.22 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)

Supriya Lifescience IPO Prospectus

Supriya Lifescience IPO Rating

Rating:Rated 4.3 stars
Vote Here ...

Supriya Lifescience IPO Listing Date

Listing Date Tuesday, December 28, 2021
BSE Script Code 543434
Listing In B Group of Securities
IPO Price ₹274 per equity share
Face Value ₹2 per equity share

Listing Day Trading Information

IPO Price
Last Trade

Company Contact Information

Supriya Lifescience Limited
207/208, Udyog Bhavan,
Sonawala Road, Goregaon,
East, Mumbai – 400063, Maharashtra, India
Phone: +91-22-40332727

Supriya Lifescience IPO Registrar

Link Intime India Private Ltd

Phone: +91-22-4918 6270

Supriya Lifescience IPO FAQs

Supriya Lifescience IPO is a main-board IPO of [.] equity shares of the face value of ₹2 aggregating up to ₹700.00 Crores. The issue is priced at ₹265 to ₹274 per equity share. The minimum order quantity is 54 Shares.

The IPO opens on Dec 16, 2021, and closes on Dec 20, 2021.

Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Zerodha customers can apply online in Supriya Lifescience IPO using UPI as a payment gateway. Zerodha customers can apply in Supriya Lifescience IPO by login into Zerodha Console (back office) and submitting an IPO application form.

Steps to apply in Supriya Lifescience IPO through Zerodha

  1. Visit the Zerodha website and login to Console.
  2. Go to Portfolio and click the IPOs link.
  3. Go to the 'Supriya Lifescience IPO' row and click the 'Bid' button.
  4. Enter your UPI ID, Quantity, and Price.
  5. ‘Submit’ IPO application form.
  6. Visit the UPI App (net banking or BHIM) to approve the mandate.

Visit Zerodha IPO Application Process Review for more detail.

The Supriya Lifescience IPO opens on Dec 16, 2021 and closes on Dec 20, 2021.

Supriya Lifescience IPO lot size is 54 Shares and the minimum order quantity is 54 Shares.

You can apply in Supriya Lifescience IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Supriya Lifescience IPO will be done on Dec 23, 2021, and the allotted shares will be credited to your demat account by Dec 27, 2021. Check the Supriya Lifescience IPO allotment status.

The Supriya Lifescience IPO listing date is on Tuesday, December 28, 2021.

Supriya Lifescience IPO Message Board

Ranked Members  Ranked Members

Open an Instant Account with Zerodha